Polymorphous light eruption

Photodermatology Photoimmunology and Photomedicine

Volumn 24, Issue 3, 2008, Pages 155-161

  Hönigsmann, Herbert ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

Author keywords

Polymorphous light eruption

Indexed keywords

ANTIMALARIAL AGENT; ANTIOXIDANT; BETA CAROTENE; COLIBIOGEN; CORTICOSTEROID; DERMATOLOGICAL AGENT; ESCHERICHIA COLI FILTRATE; IMMUNOSUPPRESSIVE AGENT; NICOTINAMIDE; POLYPODIUM LEUCOTOMOS EXTRACT; POLYUNSATURATED FATTY ACID; PSORALEN; SUNSCREEN;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DISEASE SEVERITY; ETHNIC DIFFERENCE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; PAPULOVESICULAR RASH; PATHOPHYSIOLOGY; PHOTODERMATOSIS; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PUVA; QUALITY OF LIFE; SIDE EFFECT; SKIN PIGMENTATION; SUN EXPOSURE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

CHILD; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; PHOTOSENSITIVITY DISORDERS; PHOTOTHERAPY; RISK FACTORS; SKIN; SKIN TESTS; ULTRAVIOLET RAYS;

EID: 43649088656     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2008.00343.x     Document Type: Article

References (54)

1. Morison WL, Stern RS. Polymorphous light eruption: A common reaction uncommonly recognized. Acta Derm Venereol (Stockholm) 1982; 62: 237-240.
2. Ros AM, Wennersten G. Current aspects of polymorphous light eruption in Sweden. Photodermatology 1986; 3: 298-302.
3. Pao C, Norris PG, Corbett M, Hawk JL. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994; 130: 62-64.
4. Khoo SW, Tay YK, Tham SN. Photodermatoses in a Singapore skin referral center. Clin Exp Dermatol 1996; 21: 263-268.
5. Norris PG, Hawk JLM. The idiopathic photodermatoses: Polymorphic light eruption, actinic prurigo and hydroa vacciniforme. In: Hawk JLM, ed. Photodermatology. London: Arnold, 1999; 178-190.
6. Jansen CT. The natural history of polymorphous light eruptions. Arch Dermatol 1979; 115: 165-169.
7. Kerr HA, Lim HL. Photodermatoses in African Americans: A retrospective analysis of 135 patients over a 7-year period. J Am Acad Dermatol 2007; 57: 638-643.
8. Epstein S. Studies in abnormal human sensitivity to light. IV. Photoallergic concept of prurigo aestivalis. J Invest Dermatol 1942; 5: 289-298.
9. Norris PG, Morris J, McGibbon DM, et al. Polymorphic light eruption: An immunopathological study of evolving lesions. Br J Dermatol 1989; 120: 173-183.
10. Norris PG, Barker JNWN, Allen M, et al. Adhesion molecule expression in polymorphic light eruption. J Invest Dermatol 1992; 99: 504-508.
11. Kölgen W, Van Weelden H, Den Hengst S, et al. CD11b+ cells and ultraviolet-B-resistant CD1a+ cells in skin of patients with polymorphous light eruption. J Invest Dermatol 1999; 113: 4-10.
12. Kölgen W, van Meurs M, Jongsma M, et al. Differential expression of cytokines in UV-B-exposed skin of patients with polymorphous light eruption: Correlation with Langerhans cell migration and immunosuppression. Arch Dermatol 2004; 140: 295-302.
13. Palmer RA, Friedmann PS. Ultraviolet radiation causes less immunosuppression in patients with polymorphic light eruption than in controls. J Invest Dermatol 2004; 122: 291-294.
14. van de Pas CB, Kelly DA, Seed PT, et al. Ultraviolet-radiation-induced erythema and suppression of contact hypersensitivity responses in patients with polymorphic light eruption. J Invest Dermatol 2004; 122: 295-299.
15. Schornagel IJ, Sigurdsson V, Nijhuis EHJ, et al. Decreased neutrophil skin infiltration after UVB exposure in patients with polymorphous light eruption. Invest Dermatol 2004; 123: 202-206.
16. Palmer RA, Hawk JL, Young AR, et al. The effect of solar-simulated radiation on the elicitation phase of contact hypersensitivity does not differ between controls and patients with polymorphic light eruption. J Invest Dermatol 2005; 124: 1308-1312.
17. Millard TP, Bataille V, Snieder H, et al. The heritability of polymorphic light eruption. J Invest Dermatol 2000; 115: 467-470.
18. McGregor JM, Grabczynska S, Vaughan RW, et al. Genetic modeling of abnormal photosensitivity in families with polymorphic light eruption and actinic prurigo. J Invest Dermatol 2000; 115: 471-476.
19. McFadden JP, Norris PG, Cerio R, et al. Heat shock protein 65 immunoreactivity in experimentally induced polymorphic light eruption. Acta Derm Venereol 1994; 74: 283-285.
20. Tegner E, Bradin AM Polymorphous light eruption in hypopigmented pressure areas with a UVA sunbed. Acta Derm Venereol 1986; 66: 446-448.
21. Hölzle E, Plewig G, Hofmann C, et al. Polymorphous light eruption: experimental reproduction of skin lesions. J Am Acad Dermatol 1982; 7: 111-125.
22. Ortel B, Tanew A, Wolff K, et al. Polymorphous light eruption: Action spectrum and photoprotection. J Am Acad Dermatol 1986; 14 (5 Pt 1): 748-753.
23. Van Praag MC, Boom BW, Vermeer BJ. Diagnosis and treatment of polymorphous light eruption. Int J Dermatol 1994; 33: 233-239.
24. Farr PM, Diffey BL. Adverse effects of sunscreens in photosensitive patients. Lancet 1989; 1: 429-431.
25. Baadsgaard O, Cooper KD, Lisby S, et al. Dose response and time course for induction of T6-DR+ human epidermal antigen-presenting cells by in vivo ultraviolet A, B, and C irradiation. J Am Acad Dermatol 1987; 17(5 Pt 1): 792-800.
26. Rivers JK, Norris PG, Murphy GM, et al. UVA sunbeds: Tanning, photoprotection, acute adverse effects and immunological changes. Br J Dermatol 1989; 120: 767-777.
27. Piletta PA, Salomon D, Beani JC, et al. A pilot with an itchy rash. Lancet 1996; 348: 1142.
28. Hampton PJ, Farr PM, Diffey BL, et al. Implication for photosensitive patients of ultraviolet A exposure in vehicles. Br J Dermatol 2004; 151: 873-876.
29. Palmer RA, van de Pas CB, Campalani E, et al. A simple method to assess severity of polymorphic light eruption. Br J Dermatol 2004; 151: 645-652.
30. Jansen CT, Karvonen J. Polymorphous light eruption. A seven-year follow-up evaluation of 114 patients. Arch Dermatol 1984; 120: 862-865.
31. Dover JS, Hawk JLM. Polymorphic light eruption sine eruptione. Br J Dermatol 1988; 118: 73-76.
32. Hawk J. Juvenile spring eruption is a variant of polymorphic light eruption. NZ Med J 1996; 109: 389.
33. Thomas P, Amblard P. Lucite estivale benigne. In: Thomas P, Amblard P, eds. Photodermatologie et Photothérapie. Paris: Masson, 1988; 49-51.
34. Hawk JLM, Smith NP, Black MM. The photosensitivity disorders. In: Elder DE, Elenitsas R, Jaworsky C, Johnson B Jr, eds. Lever's histopathology of the skin. Philadelphia: Lippincott-Raven, 1997; 305-310.
35. Hölzle E, Plewig G, von Kries R, et al. Polymorphous light eruption. J Invest Dermatol 1987; 88 (Suppl. 3): 32s-38s.
36. van de Pas CB, Hawk JL, Young AR, et al. An optimal method for experimental provocation of polymorphic light eruption. Arch Dermatol 2004; 140: 286-292.
37. Janssens AS, Pavel S, Ling T, Winhoven SM. Susceptibility to UV-A and UV-B provocation does not correlate with disease severity of polymorphic light eruption. Arch Dermatol 2007; 143: 599-604.
38. Ling TC, Gibbs NK, Rhodes LE. Treatment of polymorphic light eruption. Photodermatol Photoimmunol Photomed 2003; 19: 217-227.
39. Hadshiew I, Stab F, Untiedt S, et al. Effects of topically applied antioxidants in experimentally provoked polymorphous light eruption. Dermatology 1997; 195: 362-368.
40. Patel DC, Bellaney GJ, Seed PT, et al. Efficacy of short-course oral prednisolone in polymorphic light eruption: A randomized controlled trial. Br J Dermatol 2000; 143: 828-831.
41. Kontos AP, Cusack CA, Chaffins M, et al. Polymorphous light eruption in African Americans: Pinpoint papular variant. Photodermatol Photoimmunol Photomed 2002; 18: 303-306.
42. Janssens AS, Pavel S, Out-Luiting JJ, et al. Normalized ultraviolet (UV) induction of Langerhans cell depletion and neutrophil infiltrates after artificial UVB hardening of patients with polymorphic light eruption. Br J Dermatol 2005; 152: 1268-1274.
43. Hönigsmann H. Polymorphous light eruption. In: Lim HW, Soter NA, eds. Clinical photomedicine. New York: Marcel Dekker, 1993; 167-179.
44. Murphy GM, Logan RA, Lovell CR, et al. Prophylactic PUVA and UVB therapy in polymorphic light eruption-a controlled trial. Br J Dermatol 1987; 116: 531-538.
45. Bilsland D, George SA, Gibbs NK, et al. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993; 129: 708-712.
46. Man I, Dawe S, Ferguson J. Artificial hardening for polymorphic light eruption: Practical points from ten years' experience. Photodermatol Photoimmunol Photomed 1999; 15: 96-99.
47. Murphy GM, Hawk JLM, Magnus IA. Hydroxychloroquine in polymorphic light eruption: A controlled trial with drug and visual sensitivity monitoring. Br J Dermatol 1987; 116: 379-386.
48. Corbett MF, Hawk JL, Herxheimer A, et al. Controlled therapeutic trials in polymorphic light eruption. Br J Dermatol 1982; 107: 571-581.
49. Ortel B, Wechdorn D, Tanew A, et al. Effect of nicotinamide on the phototest reaction in polymorphous light eruption. Br J Dermatol 1988; 118: 669-673.
50. Przybilla B, Heppeler M, Ruzicka T. Preventive effect of an E. coli-filtrate (Colibiogen) in polymorphous light eruption. Br J Dermatol 1989; 121: 229-233.
51. Eberlein-Konig B, Fesq H, Abeck D, et al. Systemic vitamin C and vitamin E do not prevent photoprovocation test reactions in polymorphous light eruption. Photodermatol Photoimmunol Photomed 2000; 16: 50-52.
52. Norris PG, Hawk JLM. Successful treatment of severe polymorphic light eruption with azathioprine. Arch Dermatol 1989; 125: 1377.
53. Shipley DR, Hewitt JB. Polymorphic light eruption treated with cyclosporin. Br J Dermatol 2001; 144: 446-447.
54. Caccialanza M, Percivalle S, Piccinno R, Brambilla R. Photoprotective activity of oral polypodium leucotomos extract in 25 patients with idiopathic photodermatoses. Photodermatol Photoimmunol Photomed 2007; 23: 46-47.